|
1
|
Stacey GN, Connon CJ, Coopman K, Dickson AJ, Fuller B, Hunt CJ, Kemp P, Kerby J, Man J, Matejtschuk P, Moore H, Morris J, Oreffo ROC, Slater N, Ward S, Wiggins C, Zimmermann H. Preservation and stability of cell therapy products: recommendations from an expert workshop. Regen Med 2017; 12:553-564. [DOI: 10.2217/rme-2017-0073] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
If the field of regenerative medicine is to deliver therapies, rapid expansion and delivery over considerable distances to large numbers of patients is needed. This will demand efficient stabilization and shipment of cell products. However, cryopreservation science is poorly understood by life-scientists in general and in recent decades only limited progress has been made in the technology of preservation and storage of cells. Rapid translation of new developments to a broader range of cell types will be vital, as will assuring a deeper knowledge of the fundamental cell biology relating to successful preservation and recovery of cell cultures. This report presents expert consensus on these and other issues which need to be addressed for more efficient delivery of cell therapies.
Collapse
Affiliation(s)
- Glyn N Stacey
- UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, Hertfordshire, UK
| | - Che J Connon
- Institute of Genetic Medicine, University of Newcastle, Newcastle upon Tyne, UK
| | - Karen Coopman
- Chemical Engineering, Loughborough University, Loughborough, UK
| | - Alan J Dickson
- Manchester Institute of Biotechnology, University of Manchester, Manchester, UK
| | - Barry Fuller
- Department of Surgery, University College London, London, UK
| | - Charles J Hunt
- UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, Hertfordshire, UK
| | - Paul Kemp
- Intercytex Ltd & HairClone, Manchester, UK
| | - Julie Kerby
- Cell Therapy Manufacturing Development, Pfizer, Cambridge, UK
| | - Jennifer Man
- UK Stem Cell Bank, Division of Advanced Therapies, NIBSC, South Mimms, Hertfordshire, UK
| | - Paul Matejtschuk
- Standardisation Science, National Institute for Biological Standards and Control (NIBSC) a centre of the MHRA, South Mimms, Hertfordshire, UK
| | - Harry Moore
- Department of Biomedical Sciences, University of Sheffield, Sheffield, UK
| | | | - Richard OC Oreffo
- Centre for Human Development, Stem Cells & Regeneration, University of Southampton, Southampton, UK
| | - Nigel Slater
- The Bioscience Engineering Group, University of Cambridge, Cambridge, UK
| | | | - Claire Wiggins
- National Health Service – Blood & Transplant, Watford, UK
| | - Heiko Zimmermann
- Fraunhofer-Institute for Biomedical Engineering, Sulzbach, Germany
- Department of Molecular & Cellular Biotechnology/Nanotechnology, Saarland University, Saarbrücken, Germany
- Department of Marine Sciences, Universidad Católica del Norte, Antafogasta/Coquimbo, Chile
| |
Collapse
|
|
2
|
Chatterjee A, Saha D, Niemann H, Gryshkov O, Glasmacher B, Hofmann N. Effects of cryopreservation on the epigenetic profile of cells. Cryobiology 2017; 74:1-7. [DOI: 10.1016/j.cryobiol.2016.12.002] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2016] [Revised: 11/08/2016] [Accepted: 12/08/2016] [Indexed: 12/11/2022]
|